Search Results - "Pontini, Guillemette"
-
1
Immunological analysis of the murine anti‐CD3‐induced cytokine release syndrome model and therapeutic efficacy of anti‐cytokine antibodies
Published in European journal of immunology (01-08-2021)“…The aberrant release of inflammatory mediators often referred to as a cytokine storm or cytokine release syndrome (CRS), is a common and sometimes fatal…”
Get full text
Journal Article -
2
Autophagy induction by the pathogen receptor CD46
Published in Cell host & microbe (22-10-2009)“…Autophagy is a highly regulated self-degradative mechanism required at a basal level for intracellular clearance and recycling of cytoplasmic contents. Upon…”
Get full text
Journal Article -
3
Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors
Published in mAbs (01-01-2020)“…Mesothelin (MSLN) is a cell surface glycoprotein overexpressed in several solid malignancies, including gastric, lung, mesothelioma, pancreatic and ovarian…”
Get full text
Journal Article -
4
CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
Published in Experimental hematology & oncology (10-05-2022)“…CD47/SIRPα axis is recognized as an innate immune checkpoint and emerging clinical data validate the interest of interrupting this pathway in cancer,…”
Get full text
Journal Article -
5
265 CD47xPD-L1 bispecific antibodies for cancer therapy
Published in Journal for immunotherapy of cancer (01-11-2021)“…BackgroundPD-1/PD-L1 blockade can significantly improve survival across many types of cancer, but only in a minority of patients. To broaden its therapeutic…”
Get full text
Journal Article -
6
Tuning Relative Polypeptide Expression to Optimize Assembly, Yield and Downstream Processing of Bispecific Antibodies
Published in Antibodies (Basel) (01-09-2018)“…Bispecific antibodies (bsAbs) are often composed of several polypeptide chains that have to be expressed adequately to enable optimal assembly and yield of the…”
Get full text
Journal Article -
7
Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas
Published in Blood (24-10-2019)“…Antibodies that bind CD47 on tumor cells and prevent interaction with SIRPα on phagocytes are active against multiple cancer types including T-cell lymphoma…”
Get full text
Journal Article -
8
Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG
Published in Nature communications (12-02-2015)“…Bispecific antibodies enable unique therapeutic approaches but it remains a challenge to produce them at the industrial scale, and the modifications introduced…”
Get full text
Journal Article -
9
Optimizing assembly and production of native bispecific antibodies by codon de-optimization
Published in mAbs (17-02-2017)“…When production of bispecific antibodies requires the co-expression and assembly of three or four polypeptide chains, low expression of one chain can…”
Get full text
Journal Article -
10
Robust Antibody–Antigen Complexes Prediction Generated by Combining Sequence Analyses, Mutagenesis, In Vitro Evolution, X-ray Crystallography and In Silico Docking
Published in Journal of molecular biology (14-08-2015)“…Hu 15C1 is a potent anti-human Toll-like receptor 4 (TLR4) neutralizing antibody. To better understand the molecular basis of its biological activity, we used…”
Get full text
Journal Article -
11
Anti-CD79 antibody induces B cell anergy that protects against autoimmunity
Published in The Journal of immunology (1950) (15-02-2014)“…B cells play a major role in the pathogenesis of many autoimmune disorders, including rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis,…”
Get full text
Journal Article -
12
Abstract 2884: Optimized CD28 bispecific antibodies for targeted activation of T cells within the tumor microenvironment
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Tumor-targeted CD28 bispecific antibodies (bsAbs) are designed to co-stimulate T cells specifically within the tumor microenvironment. By bridging T…”
Get full text
Journal Article -
13
Abstract 2951: NI-2901, an affinity-optimized CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract To enhance efficacy of anti-PD-1/PD-L1 antibodies, many combinations with various therapeutic agents are being investigated. Blocking the CD47/SIRPα…”
Get full text
Journal Article -
14
Abstract 3428: NI-2901, a CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade with fine-tuned affinity to reduce erythrocyte binding and improve biodistribution
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Blocking the CD47/SIRPα checkpoint has recently emerged as an effective approach to mobilize the myeloid cell compartment and to improve antitumor…”
Get full text
Journal Article -
15
Abstract 3429: NI-2601, an Fc-active CD47xPD-L1 bispecific antibody that selectively targets CD47 on PD-L1-positive tumors
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract PD-1/PD-L1 blockade has improved survival across many types of cancer, but only in a minority of patients. Co-targeting PD-1/PD-L1 and the CD47/SIRPα…”
Get full text
Journal Article -
16
Caprine arthritis–encephalitis virus induces apoptosis in infected cells in vitro through the intrinsic pathway
Published in Virology (New York, N.Y.) (05-06-2008)“…Abstract Caprine arthritis–encephalitis virus (CAEV) is a lentivirus that causes natural inflammatory disease in goats, with chronic lesions in several…”
Get full text
Journal Article -
17
Optimizing assembly and production of native bispecific antibodies by codon de-optimization
Published in mAbs (17-02-2017)“…When production of bispecific antibodies requires the co-expression and assembly of three or four polypeptide chains, low expression of one chain can…”
Get full text
Report -
18
Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors
Published in mAbs (01-01-2020)“…Mesothelin (MSLN) is a cell surface glycoprotein overexpressed in several solid malignancies, including gastric, lung, mesothelioma, pancreatic and ovarian…”
Get full text
Report